Patton Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $210K | Buy |
+400
| New | +$210K | 0.05% | 449 |
|
|
2023
Q3 | – | Sell |
-4,068
| Closed | -$2.92M | – | 93 |
|
|
2023
Q2 | $2.92M | Sell |
4,068
-275
| -6% | -$198K | 0.85% | 49 |
|
|
2023
Q1 | $3.57M | Buy |
4,343
+1,008
| +30% | +$828K | 1.02% | 15 |
|
|
2022
Q4 | $2.41M | Buy |
+3,335
| New | +$2.41M | 0.7% | 47 |
|
|
2020
Q4 | – | Sell |
-2,864
| Closed | -$1.6M | – | 94 |
|
|
2020
Q3 | $1.6M | Sell |
2,864
-76
| -3% | -$42.5K | 0.87% | 50 |
|
|
2020
Q2 | $1.83M | Buy |
+2,940
| New | +$1.83M | 1.07% | 16 |
|